Top compounds associated with response to LYPD1


Feature Type Standardized
Nominal ANOVA
mRNA KHS101 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA Cyclopamine FIMM pan-cancer AAC -0.064 0.7
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.014 0.7
mRNA betulinic acid CTRPv2 pan-cancer AAC 0.017 0.7
mRNA Bexarotene FIMM pan-cancer AAC -0.065 0.7
mRNA QS11 CTRPv2 pan-cancer AAC 0.031 0.7
mRNA Sorafenib FIMM pan-cancer AAC -0.071 0.7
mRNA erismodegib CTRPv2 pan-cancer AAC -0.017 0.7
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.021 0.7
Download CSV